Search

Your search keyword '"Fon, Edward A."' showing total 529 results

Search Constraints

Start Over You searched for: Author "Fon, Edward A." Remove constraint Author: "Fon, Edward A."
529 results on '"Fon, Edward A."'

Search Results

2. Activation of parkin by a molecular glue

3. An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders

5. The neurophysiological brain-fingerprint of Parkinson’s disease

8. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

10. Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo

11. Sex-focused analyses of M83 A53T hemizygous mouse model with recombinant human alpha-synuclein preformed fibril injection identifies female resilience to disease progression: A combined magnetic resonance imaging and behavioural study.

12. Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort

14. Neuroanatomical and cognitive biomarkers of alpha‐synuclein propagation in a mouse model of synucleinopathy prior to onset of motor symptoms.

15. The C-BIG Repository: an Institution-Level Open Science Platform

17. Mechanism of Ubiquitin Ligase Activation of Parkin by a Small Molecule Molecular Glue

18. The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons

19. Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress

22. The neuro genomics partnership: A new consortium dedicated to a fully open patient to patient (P2P) integrative R&D approach

24. A deep learning convolutional neural network distinguishes neuronal models of Parkinson's disease from matched controls

26. The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons

29. Alterations of Cortical Structure and Neurophysiology in Parkinson's Disease Are Aligned with Neurochemical Systems.

30. Machine learning nominates the inositol pathway and novel genes in Parkinson's disease.

31. MerTK is a mediator of alpha-synuclein fibril uptake by human microglia.

33. A genome-wide CRISPR/Cas9 screen identifies genes that regulate the cellular uptake of α-synuclein fibrils by modulating heparan sulfate proteoglycans

34. TOM20 Gates PINK1 Activity And Mediates Its Tethering Of The TOM And TIM23 Translocases Upon Mitochondrial Stress

35. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

36. Analysis of common and rare VPS13C variants in late-onset Parkinson disease

38. A dual hit of α-synuclein internalization and immune challenge leads to the formation and maintenance of Lewy body-like inclusions in human dopaminergic neurons

41. Canadian guideline for Parkinson disease

45. Structure-based design and characterization of Parkin-activating mutations

47. Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort

50. CelltypeR: A framework to identify and characterize cell types in human midbrain organoids using flow cytometry

Catalog

Books, media, physical & digital resources